US 10285988
Compounds for treatment of fibrosis diseases
granted A61KA61K31/444A61K31/4725
Quick answer
US patent 10285988 (Compounds for treatment of fibrosis diseases) held by Curegenix, Inc. expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Curegenix, Inc.
- Grant date
- Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/444, A61K31/4725, A61K31/497, A61K31/4985